Seasteader, drug libertarian and now FDA Commissioner? Peter Thiel backs a radical shift
Once Bloomberg broke the word that Peter Thiel associate Jim O’Neill was being considered for the top job at the FDA, reporters started to nose out the most outrageous remarks had made. And there are some doozies.
The business news service started out with the most relevant: O’Neill has called for a new system that would approve drugs that establish a baseline on safety, letting consumers sort out the efficacy side of thing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.